Markel Corporation (NYSE: MKL) reported Q4 and FY 2018 results.
Operating revenues came in at $6.8 billion for the year ended December 31, 2018 compared to $6.1 billion in 2017.
Comprehensive
loss to shareholders was $375.8 million
for
the year ended December 31, 2018 compared to comprehensive income to
shareholders of $1.2 billion
in
2017.
Diluted
net loss per share was $9.55
for
the year ended December 31, 2018 compared to diluted net income per
share of $25.81 in
2017
The
combined ratio was 98% in 2018 compared to 105% in 2017.
Book
value per common share outstanding the single most important ratio in
the insurance industry declined 4% to $653.85 at December 31, 2018,
down from $683.55 at December 31, 2017.
This
was certainly a difficult quarter and fiscal year for Markel.
One
problem was the steep decline of the stock market at the end of 2018.
Therefore Markel had to recognize a comprohensive loss.
In
addition the results were also impacted by a goodwill and intangible
asset impairment of Markel CatCo operations.
The
investment results weren’t so bad.
Net
investment income surged 12.8% year over year to $114.5 million,
driven by higher short-term interest rates, dividend income from
equities, and higher interest income on the fixed-maturity
investments.
The
investment portfolio of Markel will always be more volatile than the
one of other insurers as they maintain a rather high equity portion
of 30% of total invested assets.
In
Markel Ventures total revenue climbed 18% year over year, to
$472 million.
Despite
the above mentioned setbacks Markel looks optimisticly into the
future:
The
underwriting
results for the year 2018 were positive, despite significant
catastrophe losses.
In
Q4 they completed
the acquisition of Nephila of Bermuda, the industry’s preeminent
insurance-linked securities investment manager.
So Markel remains committed to there strategy in this market segment.
For
investors the big picture and the long term perspective hasn’t
changed at all.
Markel’s
stock is valued at a price/book value per share ratio of only 1,6
At
this price Markel remains a buy!